A Phase I Study of SNX-5422 plus Erlotinib in Patients with Lung Cancer that Has Grown on Erlotinib Therapy [Protocol 13-035] |
Riely, Gregory |
- Lung Cancer, Non-Small Cell
|
A Phase II Study of Bortezomib in Patients with KRAS-Mutant Non-Small Cell Lung Cancer [Protocol 12-222] |
Riely, Gregory |
- Lung Cancer, Non-Small Cell
|
Phase I Study of PF-02341066 in People with Advanced Cancer [Protocol 07-157] |
Riely, Gregory |
|
A Phase I/II Study of Crizotinib and STA-9090 in ALK-Positive Lung Cancers [Protocol 12-015] |
Riely, Gregory |
- Lung Cancer
- Lung Cancer, Non-Small Cell
|
A Phase II Study of GSK2118436 in Patients with Advanced Non-Small Cell Lung Cancer and BRAF Mutations [Protocol 11-023] |
Riely, Gregory |
- Lung Cancer
- Lung Cancer, Non-Small Cell
|
A Phase III Study of Everolimus versus Placebo in Patients with Neuroendocrine Tumors Originating in the Lungs or Gastrointestinal Tract: The RADIANT-4 Study [Protocol 12-250] |
Reidy-Lagunes, Diane |
- Lung Cancer
- Upper Gastrointestinal
|
A Study of Degarelix Before Prostatectomy in Patients with Intermediate- to High-Risk Prostate Cancer [Protocol 11-182] |
Rathkopf, Dana |
|
A Phase IA/B Study of CC-115 in Castration-Resistant Prostate Cancer [Protocol 12-080] |
Rathkopf, Dana |
- Prostate Cancer
- Metastatic Disease after Hormone-Reducing Therapy
|
A Phase III Study of Cabozantinib versus Prednisone in Metastatic Castration-Resistant Prostate Cancer after Prior Treatment [Protocol 12-274] |
Rathkopf, Dana |
- Prostate Cancer
- Metastatic Disease after Hormone-Reducing Therapy
|
A Phase II Study of AUY922 in Patients with Myelofibrosis [Protocol 12-076] |
Rampal, Raajit |
- Hematology
- Hematologic Disorders
- Hematologic Malignancies
- Leukemia
- Myeloproliferative Neoplasm
|
Measuring Patient Satisfaction in Breast Surgery: Development and Validation of a Patient-Reported Outcomes Instrument [Protocol 05-058] |
Pusic, Andrea |
- Breast Cancer
- Survivorship
|
Development and Validation of a New Patient-Reported Outcome Instrument on the Impact of Altered Facial Appearance Following Oncologic Head and Neck Resection and Reconstruction [Protocol 07-098] |
Pusic, Andrea |
- Head & Neck Cancer
- Survivorship
|
Microvascular Reconstruction for Advanced-Stage Head and Neck Cancer Patients: A Prospective Analysis of Quality of Life and Symptom Relief [Protocol 07-150] |
Pusic, Andrea |
|
Quality of Life and Patient-Reported Outcomes After Breast Reconstruction Surgery [Protocol 12-093] |
Pusic, Andrea |
- Breast Cancer
- Survivorship
|
Expanded Access of Prochymal Infusion for the Treatment of Pediatric Patients with Acute Refractory GVHD [Protocol 09-072] |
Prockop, Susan |
- Blood and Marrow Transplantation
|
A Phase I Study of Vemurafenib in Adolescents with Inoperable Stage IIIC/IV Melanoma with V600 BRAF Mutations [Protocol 11-198] |
Pratilas, Christine |
|
A Phase II Study of Partial Breast Irradiation for Select Patients with Early Invasive or Noninvasive Breast Cancer [Protocol 10-114] |
Powell, Simon |
|
A Phase I Study of LDE225 with Etoposide and Cisplatin for the Initial Treatment of Extensive Small Cell Lung Cancer [Protocol 11-206] |
Pietanza, M. Catherine |
- Lung Cancer
- Lung Cancer, Small Cell
|
A Phase II Study of Temozolomide Alone or with ABT-888 (Veliparib) in Patients with Relapsed or Refractory Small Cell Lung Cancer [Protocol 12-021] |
Pietanza, M. Catherine |
- Lung Cancer
- Lung Cancer, Small Cell
|
A Phase III Study of Etoposide/Platinum with and without Ipilimumab in Patients with Newly Diagnosed Advanced Small Cell Lung Cancer [Protocol 12-202] |
Pietanza, M. Catherine |
- Lung Cancer
- Lung Cancer, Small Cell
|